
Orchestra BioMed receives FDA approval to initiate Virtue Trial
Orchestra BioMed Holdings, Inc. a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, has announced that the U.S. Food and Drug Administration (“FDA”) has approved its Investigational Device …